Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune System Abnormalities in Schizophrenia: An Integrative View and Translational Perspectives
Evgeny A. Ermakov, Mark M. Melamud, Valentina N. Buneva, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 91

Showing 1-25 of 91 citing articles:

Chemokine Dysregulation and Neuroinflammation in Schizophrenia: A Systematic Review
Evgeny A. Ermakov, Irina A. Mednova, Anastasiia S. Boiko, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2215-2215
Open Access | Times Cited: 46
Therapeutic management of atypical antipsychotic‑related metabolic dysfunctions using GLP‑1 receptor agonists: A systematic review
Octavian Vasiliu
Experimental and Therapeutic Medicine (2023) Vol. 26, Iss. 1
Open Access | Times Cited: 38
HERV-W ENV Induces Innate Immune Activation and Neuronal Apoptosis via linc01930/cGAS Axis in Recent-Onset Schizophrenia
Xuhang Li, Xiulin Wu, Wenshi Li, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 3000-3000
Open Access | Times Cited: 25
Prenatal and postnatal neuroimmune interactions in neurodevelopmental disorders
Eunha Kim, Jun R. Huh, Gloria B. Choi
Nature Immunology (2024) Vol. 25, Iss. 4, pp. 598-606
Closed Access | Times Cited: 11
The effects of ketogenic metabolic therapy on mental health and metabolic outcomes in schizophrenia and bipolar disorder: a randomized controlled clinical trial protocol
Calogero Longhitano, Sabine Finlay, Isabella Peachey, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 9
Circulating Cell-Free DNA Levels in Psychiatric Diseases: A Systematic Review and Meta-Analysis
Mark M. Melamud, Valentina N. Buneva, Evgeny A. Ermakov
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3402-3402
Open Access | Times Cited: 19
Association of Peripheral Inflammatory Biomarkers and Growth Factors Levels with Sex, Therapy and Other Clinical Factors in Schizophrenia and Patient Stratification Based on These Data
Evgeny A. Ermakov, Mark M. Melamud, Anastasiia S. Boiko, et al.
Brain Sciences (2023) Vol. 13, Iss. 5, pp. 836-836
Open Access | Times Cited: 16
The Cellular Dysfunction of the Brain–Blood Barrier from Endothelial Cells to Astrocytes: The Pathway towards Neurotransmitter Impairment in Schizophrenia
Stefano Stanca, Martina Rossetti, Leona Bokulic Panichi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1250-1250
Open Access | Times Cited: 7
Neuroinflammation and schizophrenia – is there a link?
Cristiano Chaves, Serdar Dursun, Massimo Tusconi, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 6
Immune Dysfunction in Schizophrenia Spectrum Disorders
Shiral S. Gangadin, Anne-Sophie D. Enthoven, Nico J.M. van Beveren, et al.
Annual Review of Clinical Psychology (2024) Vol. 20, Iss. 1, pp. 229-257
Closed Access | Times Cited: 6
Bidirectional two-sample Mendelian randomization study of differential white blood cell counts and schizophrenia
Perry B.M. Leung, Zipeng Liu, Yuanxin Zhong, et al.
Brain Behavior and Immunity (2024) Vol. 118, pp. 22-30
Open Access | Times Cited: 5
Glial-Immune Mechanisms of Schizophrenia
Kowsar Teymouri, Mahbod Ebrahimi, Jennie G. Pouget, et al.
Oxford University Press eBooks (2025), pp. 195-208
Closed Access
Long term outcomes after COVID-19 in patients with schizophrenia: a historical cohort study in a health maintenance organization
Gashaw Getaneh Dagnaw, Ora Paltiel, Asher Shafrir
Social Psychiatry and Psychiatric Epidemiology (2025)
Open Access
Schizophrenia Animal Modeling with Epidermal Growth Factor and Its Homologs: Their Connections to the Inflammatory Pathway and the Dopamine System
Hidekazu Sotoyama, Hisaaki Namba, Manavu Tohmi, et al.
Biomolecules (2023) Vol. 13, Iss. 2, pp. 372-372
Open Access | Times Cited: 14
Comprehensive bioinformatics analysis identifies hub genes associated with immune cell infiltration in early-onset schizophrenia
Shasha Wu, Tailian Xue, Yilin Li, et al.
BMC Psychiatry (2025) Vol. 25, Iss. 1
Open Access
Narcolepsy as a potential risk factor for Schizophrenia
Reyhane Eghtedarian, Anniina Tervi, Samuel E. Jones, et al.
Translational Psychiatry (2025) Vol. 15, Iss. 1
Open Access
Pan T cells, Helper T cells, and Regulatory T cells are Associated with Negative Symptoms in Persons with Anti-Gliadin Antibody Positive Schizophrenia and Related Disorders
Deepak Salem, Sarah M. Clark, Daniel Roche, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Morphological alterations of the thymus gland in individuals with schizophrenia
Qiannan Zhao, Wei Xia, Wei Yu, et al.
Molecular Psychiatry (2025)
Closed Access
Managing Psychosis of a Patient With Common Variable and Natural Killer Cell Immunodeficiencies
Michael King, Christopher Aspromonte
American Journal of Psychiatry Residents Journal (2025) Vol. 20, Iss. 3, pp. 17-19
Open Access
Parvalbumin interneuron cell-to-network plasticity: mechanisms and therapeutic avenues
Michael D. Hadler, Henrik Alle, Jörg R. P. Geiger
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 7, pp. 586-601
Open Access | Times Cited: 3
NLRP3 inflammasome mediates astroglial dysregulation of innate and adaptive immune responses in schizophrenia
Attila Szabó, Ibrahim A. Akkouh, Jordi Requena Osete, et al.
Brain Behavior and Immunity (2024)
Open Access | Times Cited: 3
Cytokines as Potential Biomarkers of Clinical Characteristics of Schizophrenia
Irina A. Mednova, Anastasiia S. Boiko, Elena G. Kornetova, et al.
Life (2022) Vol. 12, Iss. 12, pp. 1972-1972
Open Access | Times Cited: 16
Association of Single Nucleotide Polymorphisms of Cytokine Genes with Depression, Schizophrenia and Bipolar Disorder
Ekaterina V. Mikhalitskaya, N. Vyalova, Evgeny A. Ermakov, et al.
Genes (2023) Vol. 14, Iss. 7, pp. 1460-1460
Open Access | Times Cited: 9
Identifying novel proteins underlying schizophrenia via integrating pQTLs of the plasma, CSF, and brain with GWAS summary data
Xiaojing Gu, Meng Dou, Wei‐Ming Su, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 12
Counting the Toll of Inflammation on Schizophrenia—A Potential Role for Toll-like Receptors
Saahithh Redddi Patlola, Gary Donohoe, Declan P. McKernan
Biomolecules (2023) Vol. 13, Iss. 8, pp. 1188-1188
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top